STOCK TITAN

Revvity to Present at BofA Securities 2024 Health Care Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Revvity, Inc. (NYSE: RVTY) is set to present at the BofA Securities 2024 Health Care Conference on May 14, 2024. Senior Vice President and CFO Max Krakowiak will discuss the Company's strategic priorities. The presentation will be live-streamed on Revvity's website.
Revvity, Inc. (NYSE: RVTY) parteciperà alla conferenza sulla salute di BofA Securities 2024, che si terrà il 14 maggio 2024. Il Vicepresidente Senior e CFO Max Krakowiak parlerà delle priorità strategiche dell'azienda. La presentazione sarà trasmessa in diretta sul sito web di Revvity.
Revvity, Inc. (NYSE: RVTY) se presentará en la Conferencia de Salud de BofA Securities 2024 el 14 de mayo de 2024. El Vicepresidente Senior y Director Financiero, Max Krakowiak, discutirá las prioridades estratégicas de la compañía. La presentación se transmitirá en vivo en el sitio web de Revvity.
Revvity, Inc. (NYSE: RVTY)는 2024년 5월 14일에 열리는 BofA 증권 헬스케어 컨퍼런스에서 발표할 예정입니다. 수석 부사장 겸 CFO인 맥스 크라코비악은 회사의 전략적 우선순위에 대해 논의할 것입니다. 발표는 Revvity의 웹사이트에서 실시간으로 스트리밍될 예정입니다.
Revvity, Inc. (NYSE: RVTY) va présenter à la Conférence sur la Santé de BofA Securities 2024 le 14 mai 2024. Le Vice-Président Senior et CFO Max Krakowiak discutera des priorités stratégiques de l'entreprise. La présentation sera diffusée en direct sur le site web de Revvity.
Revvity, Inc. (NYSE: RVTY) wird am 14. Mai 2024 auf der BofA Securities Gesundheitskonferenz 2024 präsentieren. Der Senior Vice President und CFO Max Krakowiak wird die strategischen Prioritäten des Unternehmens erörtern. Die Präsentation wird live auf der Website von Revvity übertragen.
Positive
  • None.
Negative
  • None.

WALTHAM, Mass.--(BUSINESS WIRE)-- Revvity, Inc. (NYSE: RVTY) will present at the BofA Securities 2024 Health Care Conference on Tuesday, May 14, 2024 at 8:40 a.m. PT in Las Vegas, NV.

Senior Vice President and Chief Financial Officer Max Krakowiak will provide an update on the Company and its strategic priorities. To register, click here.

A live audio webcast will be available on the Events section of the Company’s website at www.revvity.com. A replay of the presentation will be posted on the Revvity Investor Relations website after the event and will be available for at least 30 days.

About Revvity
At Revvity, “impossible” is inspiration, and “can’t be done” is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more.

With 2023 revenue of more than $2.7 billion and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries.

Stay updated by following our Newsroom, LinkedIn, X, YouTube, Facebook and Instagram.

Investor Relations:

Steve Willoughby

steve.willoughby@revvity.com

Media Relations:

Chet Murray

(781) 663-5719

chet.murray@revvity.com

Source: Revvity

FAQ

When is Revvity presenting at the BofA Securities 2024 Health Care Conference?

Revvity is presenting at the BofA Securities 2024 Health Care Conference on Tuesday, May 14, 2024.

Who will be providing the update at the conference?

Senior Vice President and Chief Financial Officer Max Krakowiak will provide an update on Revvity and its strategic priorities at the conference.

Where can I watch the live presentation?

The live presentation will be available on the Events section of Revvity's website at www.revvity.com.

Will there be a replay of the presentation?

Yes, a replay of the presentation will be posted on the Revvity Investor Relations website after the event and will be available for at least 30 days.

PKI

NYSE:PKI

PKI Rankings

PKI Latest News

PKI Stock Data

14.46B
116.15M
0.27%
86.26%
2.79%
Analytical Laboratory Instrument Manufacturing
Manufacturing
Link
US
Boston

About PKI

PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, the company delivers unique solutions to serve the diagnostics, life sciences, food, and applied markets. IT strategically partners with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Its dedicated team of about 14,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the wellbeing and longevity of people globally. The Company reported revenue of approximately $3.8 billion in 2020, serves customers in 190 countries, and is a component of the S&P 500 index.